BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 16897811)

  • 1. Bupropion in pregnancy and the prevalence of congenital malformations.
    Cole JA; Modell JG; Haight BR; Cosmatos IS; Stoler JM; Walker AM
    Pharmacoepidemiol Drug Saf; 2007 May; 16(5):474-84. PubMed ID: 16897811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-trimester exposure to bupropion and risk of cardiac malformations.
    Louik C; Kerr S; Mitchell AA
    Pharmacoepidemiol Drug Saf; 2014 Oct; 23(10):1066-75. PubMed ID: 24920293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bupropion (amfebutamone): caution during pregnancy.
    Prescrire Int; 2005 Dec; 14(80):225. PubMed ID: 16400747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal use of bupropion and risk for congenital heart defects.
    Alwan S; Reefhuis J; Botto LD; Rasmussen SA; Correa A; Friedman JM;
    Am J Obstet Gynecol; 2010 Jul; 203(1):52.e1-6. PubMed ID: 20417496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In utero exposure to benzodiazepine. Is there a risk for anal atresia with lorazepam?].
    Bonnot O; Vollset SE; Godet PF; d'Amato T; Dalery J; Robert E
    Encephale; 2003; 29(6):553-9. PubMed ID: 15029090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smoking habits, nicotine use, and congenital malformations.
    Morales-Suárez-Varela MM; Bille C; Christensen K; Olsen J
    Obstet Gynecol; 2006 Jan; 107(1):51-7. PubMed ID: 16394039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bupropion therapy in pregnancy and the occurrence of cardiovascular malformations in infants.
    Thyagarajan V; Robin Clifford C; Wurst KE; Ephross SA; Seeger JD
    Pharmacoepidemiol Drug Saf; 2012 Nov; 21(11):1240-2. PubMed ID: 23109236
    [No Abstract]   [Full Text] [Related]  

  • 8. Major congenital malformations after first-trimester exposure to ACE inhibitors.
    Cooper WO; Hernandez-Diaz S; Arbogast PG; Dudley JA; Dyer S; Gideon PS; Hall K; Ray WA
    N Engl J Med; 2006 Jun; 354(23):2443-51. PubMed ID: 16760444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asthma exacerbations during the first trimester of pregnancy and the risk of congenital malformations among asthmatic women.
    Blais L; Forget A
    J Allergy Clin Immunol; 2008 Jun; 121(6):1379-84, 1384.e1. PubMed ID: 18410961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproic acid monotherapy in pregnancy and major congenital malformations.
    Jentink J; Loane MA; Dolk H; Barisic I; Garne E; Morris JK; de Jong-van den Berg LT;
    N Engl J Med; 2010 Jun; 362(23):2185-93. PubMed ID: 20558369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Birth defects among infants born to women who received anthrax vaccine in pregnancy.
    Ryan MA; Smith TC; Sevick CJ; Honner WK; Loach RA; Moore CA; Erickson JD
    Am J Epidemiol; 2008 Aug; 168(4):434-42. PubMed ID: 18599489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased rate of major malformations in offspring exposed to valproate during pregnancy.
    Wyszynski DF; Nambisan M; Surve T; Alsdorf RM; Smith CR; Holmes LB;
    Neurology; 2005 Mar; 64(6):961-5. PubMed ID: 15781808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serious life events and congenital malformations. A national study with a complete follow-up].
    Hansen D; Lou HC; Olsen J
    Ugeskr Laeger; 2001 Feb; 163(8):1051-7. PubMed ID: 11242661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-year survival of infants born with congenital heart defects in Arkansas (1993-1998): a survival analysis using registry data.
    Cleves MA; Ghaffar S; Zhao W; Mosley BS; Hobbs CA
    Birth Defects Res A Clin Mol Teratol; 2003 Sep; 67(9):662-8. PubMed ID: 14703791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of increased congenital malformations after first trimester exposures to angiotensin-converting enzyme inhibitors.
    Cooper WO
    J Cardiovasc Nurs; 2008; 23(1):20-4. PubMed ID: 18158502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy.
    Einarson A; Pistelli A; DeSantis M; Malm H; Paulus WD; Panchaud A; Kennedy D; Einarson TR; Koren G
    Am J Psychiatry; 2008 Jun; 165(6):749-52. PubMed ID: 18381907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal smoking and congenital heart defects.
    Malik S; Cleves MA; Honein MA; Romitti PA; Botto LD; Yang S; Hobbs CA;
    Pediatrics; 2008 Apr; 121(4):e810-6. PubMed ID: 18381510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal birthplace and major congenital malformations among New York Hispanics.
    Zhu M; Druschel C; Lin S
    Birth Defects Res A Clin Mol Teratol; 2006 Jun; 76(6):467-73. PubMed ID: 16933210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta2-agonists use during pregnancy and the risk of congenital malformations.
    Eltonsy S; Forget A; Blais L
    Birth Defects Res A Clin Mol Teratol; 2011 Nov; 91(11):937-47. PubMed ID: 21948561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study.
    Chun-Fai-Chan B; Koren G; Fayez I; Kalra S; Voyer-Lavigne S; Boshier A; Shakir S; Einarson A
    Am J Obstet Gynecol; 2005 Mar; 192(3):932-6. PubMed ID: 15746694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.